- Home
- MLYS vs HSTM Comparison
MLYS vs HSTM Comparison
Compare MLYS & HSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- HSTM
- Stock Information
- Founded
- MLYS 2019
- HSTM 1990
- Country
- MLYS United States
- HSTM United States
- Employees
- MLYS N/A
- HSTM N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- HSTM Computer Software: Programming Data Processing
- Sector
- MLYS Health Care
- HSTM Technology
- Exchange
- MLYS Nasdaq
- HSTM Nasdaq
- Market Cap
- MLYS 890.6M
- HSTM 828.5M
- IPO Year
- MLYS 2023
- HSTM 2000
- Fundamental
- Price
- MLYS $14.89
- HSTM $27.74
- Analyst Decision
- MLYS Strong Buy
- HSTM Hold
- Analyst Count
- MLYS 4
- HSTM 2
- Target Price
- MLYS $27.00
- HSTM $28.00
- AVG Volume (30 Days)
- MLYS 869.6K
- HSTM 185.5K
- Earning Date
- MLYS 08-12-2025
- HSTM 10-20-2025
- Dividend Yield
- MLYS N/A
- HSTM 0.45%
- EPS Growth
- MLYS N/A
- HSTM 14.03
- EPS
- MLYS N/A
- HSTM 0.67
- Revenue
- MLYS N/A
- HSTM $295,211,000.00
- Revenue This Year
- MLYS N/A
- HSTM $4.90
- Revenue Next Year
- MLYS N/A
- HSTM $5.12
- P/E Ratio
- MLYS N/A
- HSTM $41.13
- Revenue Growth
- MLYS N/A
- HSTM 3.50
- 52 Week Low
- MLYS $8.24
- HSTM $25.36
- 52 Week High
- MLYS $18.38
- HSTM $34.24
- Technical
- Relative Strength Index (RSI)
- MLYS 55.68
- HSTM 63.11
- Support Level
- MLYS $14.26
- HSTM $26.28
- Resistance Level
- MLYS $15.55
- HSTM $26.83
- Average True Range (ATR)
- MLYS 0.85
- HSTM 0.59
- MACD
- MLYS 0.18
- HSTM 0.19
- Stochastic Oscillator
- MLYS 77.53
- HSTM 98.65
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.